Prof. Motti Gerlic

Motti Gerlic is a Full Professor in the Gray School of Medical Sciences at Tel Aviv University. He obtained his PhD (Direct track) at Ben Gurion University, followed by a CCFA postdoctoral fellowship at Sanford Burnham Prebys Medical Discovery Institute (SBP), San Diego. Prof. Gerlic joined Tel Aviv University following a research officer position at WHEI & Melbourne University.  

His laboratory research centers on the intersection of innate immune responses and inflammatory cell death, specifically necroptosis and pyroptosis, to ultimately harness this knowledge to fight cancer and improve the health of infectious and inflammatory diseases patients. Prof. Gerlic's work focuses on novel NLRs (Nucleotide-binding domain and Leucine-rich repeat containing Receptors) and understanding how the innate immune system recognizes pathogens (viruses and bacteria) to trigger inflammatory signals, and how pathogens evolve to counteract these mechanisms.